12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Intermezzo zolpidem regulatory update

FDA accepted for review the resubmission of an NDA from Transcept for Intermezzo zolpidem to treat insomnia when a middle of the night awakening is followed by difficulty returning to...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >